Beta Bionics, Inc. (BBNX)
Beta Bionics Market Cap : 603.14M for Feb. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Abbott Laboratories | 195.12B |
| Insulet Corp. | 17.02B |
| Tandem Diabetes Care, Inc. | 1.666B |
| Accuray, Inc. | 60.67M |
| Plus Therapeutics, Inc. | 37.79M |
Market Cap Related Metrics
| PS Ratio | 5.967 |
| PEG Ratio | -0.2496 |
| Price to Book Value | 2.097 |
| Price | 13.70 |
| Earnings Yield | -12.26% |
| PEGY Ratio | -0.2496 |